These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28889370)

  • 1. Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.
    Cerruti L; Bleyzac N; Tod M
    Clin Pharmacokinet; 2018 Jul; 57(7):831-841. PubMed ID: 28889370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
    Mahmood I
    J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
    Kanamori M; Takahashi H; Echizen H
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
    Björkman S
    Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mahmood I; Ahmad T; Mansoor N; Sharib SM
    J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug clearance in children.
    Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
    J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
    Mahmood I
    Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
    Calvier EA; Krekels EH; Välitalo PA; Rostami-Hodjegan A; Tibboel D; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2017 Mar; 56(3):273-285. PubMed ID: 27510367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
    Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.
    Mahmood I
    Drugs R D; 2020 Mar; 20(1):1-10. PubMed ID: 31820365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allometry Is a Reasonable Choice in Pediatric Drug Development.
    Liu T; Ghafoori P; Gobburu JV
    J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.
    Strougo A; Yassen A; Monnereau C; Danhof M; Freijer J
    J Clin Pharmacol; 2014 Sep; 54(9):1006-15. PubMed ID: 24676942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug clearance in children: an evaluation of the predictive performance of several models.
    Mahmood I; Staschen CM; Goteti K
    AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure.
    Carcillo JA; Doughty L; Kofos D; Frye RF; Kaplan SS; Sasser H; Burckart GJ
    Intensive Care Med; 2003 Jun; 29(6):980-984. PubMed ID: 12698250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.
    Mahmood I; Tegenge MA
    Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.
    Tang H; Mayersohn M
    J Pharm Sci; 2006 Aug; 95(8):1783-99. PubMed ID: 16795013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants.
    Tegenge MA; Mahmood I; Jiang Z; Forshee R
    J Clin Pharmacol; 2018 Jul; 58(7):877-884. PubMed ID: 29489016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.